Discover

DXCM
DexCom, Inc.
92.34
2 x 83.86
2 x 97.15
bid
ask
+
2.12
2.35%
2 @ 07:56 PM
92.23 -0.11 (0.12%)
Ytd39.13%
1y14.54%
89.20
day range
92.56
54.84
52 week range
92.34
Open89.61Prev Close90.22Low89.20High92.56Mkt Cap34.85B
Vol3.48MAvg Vol5.24MEPS2.53P/E36.50Forward P/E29.55
Beta1.41Short Ratio3.68Inst. Own106.34%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning10-2950-d Avg77.63200-d Avg69.321yr Est94.12
Earning
DateForEstimateReportedSurprisesurprise %
2026-10-292026-090.66N/AN/AN/A
2026-07-302026-060.610.70.0914.57%
2026-04-302026-030.470.560.0920.27%
2026-02-122025-120.650.680.034.62%
2025-10-302025-090.580.610.035.90%
2025-07-302025-060.440.480.048.21%
Upgrade / Downgrade
DateFirmActionFromTo
2026-08-04Argus ResearchUpgradeBuyBuy
2026-08-03Canaccord GenuityUpgradeBuyBuy
2026-07-31CitigroupUpgradeBuyBuy
2026-07-31RBC CapitalUpgradeOutperformOutperform
2026-07-31MizuhoUpgradeOutperformOutperform
2026-07-31JP MorganUpgradeNeutralNeutral
Profile
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems for the management of diabetes and metabolic health in the United States and internationally. The company offers Dexcom G7 and G7 15 Day, an integrated continuous glucose monitoring system; Dexcom G6, a CGM system; Dexcom ONE+ to replace fingerstick blood glucose testing for diabetes treatment decisions; Stelo, a biosensor designed for adults with prediabetes and Type 2 diabetes who do not use insulin; Dexcom Share, a remote monitoring system; and Dexcom Follow application. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California.
Insider Holder
DateNameRelationQuantityDescription
2026-05-27ALTMAN STEVEN RDirector69.23KStock Award(Grant)
2026-08-13BROWN MICHAEL JONOfficer102.95KSale
2026-06-03COLEMAN JONOfficer95.45KSale
2026-05-27COLLINS RICHARD ALEXANDERDirector45.77KStock Award(Grant)
2026-08-02FOLETTA MARK GDirector0.00Sale
2026-03-05LEACH JACOB STEVENChief Executive Officer469.11KStock Award(Grant)
Institution Ownership
Report DateOrganizationPositionValuePercentage
2026-06-29Blackrock Inc.38.24M3.53B10.13%
2026-06-29Vanguard Capital Management LLC25.21M2.33B6.68%
2026-06-29Vanguard Portfolio Management LLC19.66M1.82B5.21%
2026-06-29State Street Corporation18.38M1.70B4.87%
2026-06-29Invesco Ltd.15.29M1.41B4.05%
2026-06-29BAILLIE GIFFORD & CO14.80M1.37B3.92%
Fund Ownership
Report DateOrganizationPositionValuePercentage
2026-03-30VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund12.22M1.13B3.24%
2026-03-30VANGUARD INDEX FUNDS-Vanguard 500 Index Fund9.78M903.03M2.59%
2026-03-30VANGUARD INDEX FUNDS-Vanguard Mid-Cap Index Fund8.31M767.50M2.20%
2026-06-29Invesco QQQ Trust, Series 18.19M756.36M2.17%
2026-04-29VANGUARD SPECIALIZED FUNDS-Vanguard Health Care Fund6.37M587.76M1.69%
2026-06-29iShares Trust-iShares Core S&P 500 ETF5.33M492.23M1.41%
Split
SplitDate
4 : 12022-06-13
4 : 12022-06-10